These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 21575799

  • 21. The rebirth of progesterone in the prevention of preterm labor.
    Schmouder VM, Prescott GM, Franco A, Fan-Havard P.
    Ann Pharmacother; 2013 Apr; 47(4):527-36. PubMed ID: 23535817
    [Abstract] [Full Text] [Related]

  • 22. Why the United States preterm birth rate is declining.
    Schoen CN, Tabbah S, Iams JD, Caughey AB, Berghella V.
    Am J Obstet Gynecol; 2015 Aug; 213(2):175-80. PubMed ID: 25511243
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.
    Romero R, Stanczyk FZ.
    Am J Obstet Gynecol; 2013 Jun; 208(6):421-6. PubMed ID: 23643669
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage.
    Mackeen AD, Rafael TJ, Zavodnick J, Berghella V.
    Am J Perinatol; 2013 Oct; 30(9):755-8. PubMed ID: 23341330
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM, Ashwood P, Flenady V, Jenkins-Manning S, Cincotta R, Crowther CA.
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298
    [Abstract] [Full Text] [Related]

  • 33. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
    González-Quintero VH, Istwan NB, Rhea DJ, Smarkusky L, Hoffman MC, Stanziano GJ.
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):249-52. PubMed ID: 17437227
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.
    Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.